European Patients’ Academy (EUPATI) toolbox

Published by IRDiRC

Research and Drug Development Orphan Drug Patient Information Toolkit for Patient EUPATI Toolbox Patient Training

The EUPATI Academy is the only in-depth training program for patient experts so far in EU that lasts 14months.
It includes an on online training program supported with two weeks of F2F training. The Academy is still operated by EPF, providing high quality training in drug development to patient from EMEA.

View this resource Bookmark this resource

European Patients’ Academy (EUPATI) toolbox

Published by IRDiRC

Research and Drug Development Orphan Drug Patient Information Toolkit for Patient EUPATI Toolbox Patient Training

View this resource Bookmark this resource

EURORDIS Open Academy

Published by IRDiRC

Orphan Drug Patient Information Toolkit for EURORDIS Open Academy Training Programme Research and Drug Development

The training aims to provide participants with the knowledge and skills needed to become experts in medicines research and development. Over 20 EURORDIS Summer School trainers provide the training each year.

View this resource Bookmark this resource

EU planned cross-border treatments

Published by IRDiRC

Research and Drug Development Orphan Drug Early Access Support Patient Information EU Planned Cross-Border Treatment

Different ways to access the health care structures and professionals of the foreign EU Country National Health System (NHS) for people insured in the EU countries.

View this resource Bookmark this resource

European Network of Paediatric Research at the European Medicines Agency

Published by IRDiRC

Research and Drug Development Regulatory Affairs Orphan Drug Early Access Support Paediatric Medicine European Network of Paediatric Research

The European Network of Paediatric Research at the European Medicines Agency (Enpr- EMA) is a network of research networks, investigators and centres with recognised expertise in performing clinical studies in children. Enpr-EMA enables networking and collaboration with members from within and outside the European Union (EU), including academia and the pharmaceutical industry

View this resource Bookmark this resource

Connect 4 Children (C4C) – Paediatric Clinical Research Networks

Published by IRDiRC

Orphan Drug Research and Drug Development Network C4C Clinical Research Network

c4c (connect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population.

View this resource Bookmark this resource

EU Compassionate Use Programs

Published by IRDiRC

European Union Research and Drug Development Regulatory Affairs Clinical Development Orphan Drug Early Access Support Compassionate Use EMA Compassionate Use

Compassionate use is a treatment option that allows the use of an unauthorised medicine. Under strict conditions, products in development can be made available to groups of patients who have a disease with no satisfactory authorised therapies and who cannot enter clinical trials.

View this resource Bookmark this resource

IMT Feedback

Did the IMT help you in finding the resource you needed?

European Patients’ Academy (EUPATI) toolbox

European Patients’ Academy (EUPATI) toolbox

EURORDIS Open Academy

EU planned cross-border treatments

European Network of Paediatric Research at the European Medicines Agency

Connect 4 Children (C4C) – Paediatric Clinical Research Networks

EU Compassionate Use Programs

IMT Cookie Overview